当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 现金流量表

鲁抗医药

(600789)

  

流通市值:74.86亿  总市值:87.06亿
流通股本:8.99亿   总股本:10.45亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,268,662,185.395,116,633,874.443,758,129,493.312,514,245,995.38
  收到的税费返还17,636,848.4634,497,737.2337,746,605.6628,215,771.94
  收到其他与经营活动有关的现金27,256,147119,255,037.06105,959,319.488,626,164.17
  经营活动现金流入小计1,313,555,180.855,270,386,648.733,901,835,418.372,631,087,931.49
  购买商品、接受劳务支付的现金822,357,277.983,039,220,239.752,532,137,292.621,580,248,428.59
  支付给职工以及为职工支付的现金189,944,925.81737,756,843.62530,362,214.65349,428,640
  支付的各项税费34,817,077.6188,908,016.59154,086,477.76115,642,659.44
  支付其他与经营活动有关的现金102,312,820.15606,327,699.75379,306,873.76273,430,924.88
  经营活动现金流出小计1,149,432,101.544,572,212,799.713,595,892,858.792,318,750,652.91
  经营活动产生的现金流量净额164,123,079.31698,173,849.02305,942,559.58312,337,278.58
二、投资活动产生的现金流量:
  收回投资收到的现金-1,189,693.63--
  处置固定资产、无形资产和其他长期资产收回的现金净额18,812,647.71104,201,617.5994,701,901.729,084,163.2
  投资活动现金流入小计18,812,647.71105,391,311.2294,701,901.729,084,163.2
  购建固定资产、无形资产和其他长期资产支付的现金38,303,519.16338,862,954.47209,213,507.48134,413,489.79
  投资活动现金流出小计38,303,519.16338,862,954.47209,213,507.48134,413,489.79
  投资活动产生的现金流量净额-19,490,871.45-233,471,643.25-114,511,605.78-105,329,326.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,186,829,138.68--
  取得借款收到的现金349,547,5001,875,320,580.491,349,991,458.24861,378,558.24
  收到其他与筹资活动有关的现金-100,000,000--
  筹资活动现金流入小计349,547,5003,162,149,719.171,349,991,458.24861,378,558.24
  偿还债务支付的现金699,388,658.241,639,338,422.231,343,807,459.73872,111,459.73
  分配股利、利润或偿付利息支付的现金11,969,449.85167,300,555.68151,834,671.05112,050,425.73
  其中:子公司支付给少数股东的股利、利润-1,002,800--
  支付其他与筹资活动有关的现金679,245.28200,000,000--
  筹资活动现金流出小计712,037,353.372,006,638,977.911,495,642,130.78984,161,885.46
  筹资活动产生的现金流量净额-362,489,853.371,155,510,741.26-145,650,672.54-122,783,327.22
四、汇率变动对现金及现金等价物的影响-5,283,354.812,244,815.34,725,522.795,177,073.16
五、现金及现金等价物净增加额-223,141,000.321,622,457,762.3350,505,804.0589,401,697.93
  加:期初现金及现金等价物余额2,118,158,954.3495,701,191.97495,701,191.97495,701,191.97
  期末现金及现金等价物余额1,895,017,953.982,118,158,954.3546,206,996.02585,102,889.9
补充资料:
  净利润-111,906,367.03-110,648,217.65
  资产减值准备-45,731,523.35-44,919,839.14
  固定资产和投资性房地产折旧-384,169,213.68-189,019,231.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-384,169,213.68-189,019,231.64
  无形资产摊销-64,898,995.97-23,289,598.57
  长期待摊费用摊销-471,364.08-207,786.3
  处置固定资产、无形资产和其他长期资产的损失--168,153.08--54,688.61
  固定资产报废损失-179,201.08-329.76
  公允价值变动损失-71,340-71,340
  财务费用-63,541,194.82-26,072,458.63
  投资损失-5,220,411.67-2,083,662.72
  递延所得税--16,491,379.72-1,313,955.54
  其中:递延所得税资产减少--16,491,379.72-1,313,955.54
  存货的减少-191,085,798.16-171,901,889.75
  经营性应收项目的减少-169,326,364.6--136,345,643.17
  经营性应付项目的增加--331,301,202.67--140,485,944.07
  其他-3,349,708.54-632,542.63
  现金的期末余额-2,118,158,954.3-585,102,889.9
  减:现金的期初余额-495,701,191.97-495,701,191.97
  现金及现金等价物的净增加额-1,622,457,762.33-89,401,697.93
公告日期2026-04-252026-04-252025-10-312025-08-28
审计意见(境内)标准无保留意见
TOP↑